SIGNIFY HEALTH INC -CLASS A (SGFY) Fundamental Analysis & Valuation
NYSE:SGFY • US82671G1004
Current stock price
30.49 USD
+0.02 (+0.07%)
At close:
30.49 USD
0 (0%)
After Hours:
This SGFY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SGFY Profitability Analysis
1.1 Basic Checks
- SGFY had negative earnings in the past year.
- In the past year SGFY had a positive cash flow from operations.
1.2 Ratios
- The profitability ratios for SGFY are negative, so there is not much use analyzing them.
- SGFY has a better Return On Invested Capital (6.14%) than 67.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 6.14% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Operating Margin value of 13.53%, SGFY belongs to the best of the industry, outperforming 89.38% of the companies in the same industry.
- SGFY's Operating Margin has improved in the last couple of years.
- With a decent Gross Margin value of 45.33%, SGFY is doing good in the industry, outperforming 72.57% of the companies in the same industry.
- In the last couple of years the Gross Margin of SGFY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% |
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
2. SGFY Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SGFY is destroying value.
- Compared to 1 year ago, SGFY has more shares outstanding
- The debt/assets ratio for SGFY is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.36 indicates that SGFY is not in any danger for bankruptcy at the moment.
- The Altman-Z score of SGFY (3.36) is better than 76.99% of its industry peers.
- SGFY has a debt to FCF ratio of 93.50. This is a negative value and a sign of low solvency as SGFY would need 93.50 years to pay back of all of its debts.
- SGFY has a Debt to FCF ratio (93.50) which is in line with its industry peers.
- SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
- SGFY has a better Debt to Equity ratio (0.53) than 60.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Altman-Z | 3.36 |
ROIC/WACC0.66
WACC9.37%
2.3 Liquidity
- SGFY has a Current Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
- SGFY has a Current ratio of 1.62. This is in the better half of the industry: SGFY outperforms 67.26% of its industry peers.
- A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
- The Quick ratio of SGFY (1.62) is better than 72.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. SGFY Growth Analysis
3.1 Past
- The earnings per share for SGFY have decreased strongly by -390.91% in the last year.
- The Revenue has grown by 23.33% in the past year. This is a very strong growth!
- SGFY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
3.2 Future
- The Earnings Per Share is expected to grow by 93.52% on average over the next years. This is a very strong growth
- SGFY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.33% yearly.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. SGFY Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
- SGFY is valuated quite expensively with a Price/Forward Earnings ratio of 94.60.
- SGFY's Price/Forward Earnings is on the same level as the industry average.
- SGFY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 |
4.2 Price Multiples
- SGFY's Enterprise Value to EBITDA ratio is in line with the industry average.
- SGFY's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1516.44 | ||
| EV/EBITDA | 32.74 |
4.3 Compensation for Growth
- SGFY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- SGFY's earnings are expected to grow with 93.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A
5. SGFY Dividend Analysis
5.1 Amount
- SGFY has a Yearly Dividend Yield of 1.26%.
- SGFY's Dividend Yield is rather good when compared to the industry average which is at 0.50. SGFY pays more dividend than 85.84% of the companies in the same industry.
- Compared to the average S&P500 Dividend Yield of 1.89, SGFY is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
- SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
SGFY Fundamentals: All Metrics, Ratios and Statistics
30.49
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-07 2023-03-07/dmh
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Revenue(TTM)805.50M
Net Income(TTM)-576.80M
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 | ||
| P/S | 6.78 | ||
| P/FCF | 1516.44 | ||
| P/OCF | 171.13 | ||
| P/B | 8.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.74 |
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 6.14% | ||
| ROICexc | 9.77% | ||
| ROICexgc | N/A | ||
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Debt/EBITDA | 2.07 | ||
| Cap/Depr | 52.6% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | 3.36 |
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A
SIGNIFY HEALTH INC -CLASS A / SGFY Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for SIGNIFY HEALTH INC -CLASS A?
ChartMill assigns a fundamental rating of 4 / 10 to SGFY.
Can you provide the valuation status for SIGNIFY HEALTH INC -CLASS A?
ChartMill assigns a valuation rating of 3 / 10 to SIGNIFY HEALTH INC -CLASS A (SGFY). This can be considered as Overvalued.
What is the profitability of SGFY stock?
SIGNIFY HEALTH INC -CLASS A (SGFY) has a profitability rating of 1 / 10.
Can you provide the financial health for SGFY stock?
The financial health rating of SIGNIFY HEALTH INC -CLASS A (SGFY) is 6 / 10.